13 | DD N | KaiserSose | 09/30/2013 3:37:33 AM |
12 | $CVSL link to Conference Call: | KaiserSose | 09/30/2013 3:34:08 AM |
11 | CVSL Announces Letter Of Intent To Acquire | MicroCapStocksRock | 05/11/2013 3:28:54 PM |
10 | CVSL Computer Vision Systems laboratories Corp. | Rosner | 04/21/2013 8:08:09 PM |
9 | annual report out http:/ | IDFIX | 04/17/2013 10:40:07 AM |
8 | $CVSL NOW MAKING $100MILLION IN REVENUES READ | IDFIX | 04/17/2013 10:10:38 AM |
7 | Billionar CEO Mr. Rochon stated that having | IDFIX | 04/17/2013 10:09:38 AM |
6 | CVSL 0.244 | IDFIX | 04/17/2013 10:08:42 AM |
5 | CVSL CEO is a BILLIONAR and WILL PUSH HIS STOCK | IDFIX | 04/16/2013 1:10:14 PM |
4 | add me as ass mod | IDFIX | 04/16/2013 1:09:23 PM |
3 | $CVSL - on it Phil' !!! | IDFIX | 04/16/2013 1:09:02 PM |
2 | CVSL Computer Vision Systems Laboratories Corp. | Stock Buff | 04/13/2013 11:29:40 PM |
1 | $CVSL Alert for $1.00 per share ~ | MicroCapStocksRock | 01/20/2013 11:32:10 AM |
Recent Articles
- Moleculin Biotech's Q1 2025 Update: Progress and Results Ahead
- ADC Therapeutics Showcases LOTIS-7 Clinical Data at Global Conference
- Pharmaceutical Container Market Forecast: Exponential Growth Ahead
- Jacobs Inks Deal as Integrated Partner for Energy Project
- Unlocking Decentralization with UXUY Protocol's Innovations
- Job Seekers Reveal Economic Woes and Workplace Dissatisfaction
- Waterfall Network Launches Groundbreaking Tools for Web3 Innovation
- INE Security Enhances Cyber Defense Training with New Labs
- Pioneering Gene Therapy at Lurie Children's for Skin Disorders
- A Partnership for Growth: Glass House Brands and LEEF Team Up
- Strategic Partnership Between Glass House Brands and LEEF
- Avis Budget Group Announces Major $500 Million Notes Offering
- nCino Schedules Conference Call for First Quarter Results
- BioVie Announces Virtual Event for Parkinson's Treatment Discussion
- Stallion Uranium Faces Cease Trade Order and Future Plans
- Gain Therapeutics Highlights Progress and Financial Health in 2025
- PDS Biotech Expands Clinical Trials and Financial Overview
- Abeona Therapeutics Expands Access to Innovative Skin Disorder Treatment
- Quoin Pharmaceuticals Reports Encouraging Clinical Results for QRX003
- Engagement of Altimmune at Notable Investor Conferences Ahead
- Highland Copper Advances Copperwood Project with Engineering Efforts
- Promising Outcomes of REYOBIQ in Treating Leptomeningeal Metastases
- Creative Realities' Fiscal Q1 Report: Insights and Future Plans
- Anavex Life Sciences Prepares for Major Healthcare Events
- Pyxis Oncology Set for Key Investor Conferences Soon
- Bombardier's Strategic Move: New Notes Issuance to Manage Debt
- Pony AI's Founders Commit to Extended Lock-Ups to Strengthen Trust
- Emergent BioSolutions' Executive Participation in Key Conferences
- Advanced Flower Capital Inc. Reports Strong Q1 Performance 2025
- Arabsat and Telesat Join Forces for Revolutionary Connectivity
- SolaXCloud's Cybersecurity Strategy to Comply with NIS2
- Partnering in Angola: Sintana Energy and Corcel plc's Vision
- Technology and Public Welfare: Huabochuangke's Vision Unveiled
- MediPharm Labs Reaches Key Milestones with Q1 2025 Performance
- DeFi Technologies Reports Stellar Q1 2025 Financial Results
- Mountain Province Diamonds Secures CAD$33 Million Funding Boost
- Rupali Sawhney Takes Lead as Chief Customer Officer at Otelier
- Federal Realty Investment Trust Sells Levare Apartments for $74M
- Palatin Technologies Reports Impressive Q3 2025 Results
- Maury Donnelly & Parr: A Legacy of Service for 150 Years
- Aspen Aerogels to Showcase Innovations at Annual Investor Event
- Metrika and S&P Global Ratings Innovate Digital Asset Risk Insights
- TCL Achieves Global Design Excellence with 17 Awards
- Easy Street Capital Enhances Financing Access for Investors
- The Impact of Pets on Community Health and Well-Being
- Insights from Callan on 2025 Defined Contribution Trends
- Funding for Housing Stability: A Major Grant Impacting Lives
- PussFi Unveils $PUSS: A Memetic Token with Genuine Utility
- Charlotte's Web Sees Promising Growth in Q1 Results for 2025
- Innovative Collaboration Drives Cancer Education and Research Forward